IART
Integra Lifesciences Holdings CorpCompany with tickers: IART
CIK
917520
CUSIP
457985208
Shares Outstanding
77,796,903
Website
https://www.integralife.com
13F Activity (30d)
3 filings
2 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$225,000,000
as of 2023-07-18
· not restated in filings since 2025-02-25
Remaining Authorization
$50,000,000
as of 2026-03-31
Program Utilization
77.8%
$175,000,000 used of $225,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 | $221,000 | 10-K, filed 2026-02-26 | ||
| 2024-12-31 | $52,471,000 | 10-K, filed 2026-02-26 | ||
| 2023-12-31 | $275,000,000 | 10-K, filed 2026-02-26 | ||
| 2022-12-31 | $125,000,000 | 10-K, filed 2025-02-25 | ||
| 2021-12-31 | $0 | 10-K, filed 2024-02-28 | ||
| 2020-12-31 | $100,000,000 | 10-K, filed 2023-02-22 | ||
| 2019-12-31 | $0 | 10-K, filed 2022-02-24 | ||
| 2018-12-31 | $0 | 10-K, filed 2021-02-23 | ||
| 2013-12-31 | $0 | 10-K, filed 2014-02-27 | ||
| 2012-12-31 | $0 | 10-K, filed 2014-02-27 | ||
| 2011-12-31 | $83,463,000 | 10-K, filed 2014-02-27 | ||
| 2010-12-31 | $31,278,000 | 10-K, filed 2013-02-26 | ||